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Abstract
Interactions between exposure to ambient air pollutants and respiratory pathogens have been 
shown to modify respiratory immune responses. Emerging data suggest key roles for Toll-like 
receptor (TLR) and nucleotide-binding oligomerization domain–like receptor (NLR) signaling in 
pathogen-induced immune responses. Similarly, immune responses elicited by exposure to air 
pollutants are mediated by specific TLR- and NLR-dependent mechanisms. This review article 
will summarize current knowledge about how air pollutants modify TLR- and NLR-dependent 
signaling and host defense responses in the lung.
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Since the 1970 Clean Air Act, many cities have experienced dramatic improvements in air 
quality. Levels of large particulate matter (PM10) have decreased by 83% in this period, 
even though there has been an increase of 178% in the number of vehicle miles traveled.1 
Despite these advances, the American Lung Association estimates that more than half of 
persons in the United States live in counties that have unhealthy levels of pollution.2 The 
last 40 years has also seen important advancements in our understanding of the risks posed 
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by high levels of both indoor and outdoor air pollutants on respiratory health. Accordingly, 
numerous reviews have described the potential of gaseous pollutants, such as ozone, and 
particulate pollutants, such as diesel, cigarette smoke (CS), and biomass, to impair lung 
function and exacerbate and promote asthma.3,4 In addition to direct physiologic changes, 
many have highlighted the ability of these agents to modulate the adaptive immune response 
and thereby increase IgE levels and promote a TH2 milieu that can promote allergic airway 
disease.5 Recently, there has been a growing appreciation that pollutants might also 
significantly affect respiratory innate immune responses.
Therefore here we will review the potential cellular mechanisms by which exposure to air 
pollutants modulates respiratory immunity and host defense. The public health significance 
is clear: respiratory tract infections are among the most common source of illness in the 
United States and Europe. Their effects are felt most acutely in susceptible populations, such 
as children, the elderly, and asthmatic patients. Focusing on the role of Toll-like receptors 
(TLRs) and nucleotide-binding oligomerization domain (NOD)–like receptors (NLRs), this 
review will summarize current evidence on how air pollutants might alter innate immunity.
POLLUTANTS AND HEALTH RISKS FROM RESPIRATORY TRACT 
INFECTIONS
The strongest evidence of a link between pollutants and respiratory tract infections comes 
from studies in the developing world of those exposed to the high levels of particles 
generated from the combustion of biomass fuels (eg, wood and dung) for cooking or 
heating. Chronic bronchitis, acute respiratory tract infections, recurrent pneumonia, and 
tuberculosis have all been shown to be significantly more prevalent in mothers who cook or 
their children.6 Fewer studies have been completed in the developed world, where better 
ventilation results in much lower exposure levels. These studies tend to show an increased 
risk of acute respiratory tract infections from woodstoves.7 Similarly, exposure to CS has 
long been thought to reduce host defense because smokers have much higher rates of 
respiratory tract infections.8 Numerous studies have now shown that secondhand smoke can 
also significantly increase the risk from lower respiratory tract infections in children and 
infants.9,10
The United States Environmental Protection Agency is mandated to set National Ambient 
Air Quality Standards for 6 criteria pollutants, including ozone and PM. These have tended 
to receive the most attention of the studies on air pollution and respiratory health effects. 
Evidence of increased susceptibility to infections from ambient pollutants has come from 
experimental pulmonary infections. For example, in mice infected with bacteria, exposure to 
low levels of ozone will increase mortality.11 Population-based studies have supported these 
findings but have not been conclusive because of methodological problems. For example, 
multiple epidemiologic studies have now shown an association between increases in ambient 
ozone or PM levels and hospital admissions for respiratory disease.12–16 Unfortunately, the 
difficulty in ascertaining the role of pulmonary infections in these studies limits our ability 
to determine whether this was due to the pollutants acting on susceptible airways, as in 
patients with asthma or chronic obstructive pulmonary disease (COPD), or rather an 
impaired immune response to an infection after pollutant exposure. Hospital visits for PM-
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induced asthma are more prevalent in children and the elderly,15,16 yet in these 
subpopulations viral infection is a primary driver of exacerbations. Complicating the issue is 
that agents like ozone can cause inflammation and alter the immune system while also 
having an independent effect on lung function.17
As we detail below, pollutants from biomass, CS, and ambient air can work through 
common mechanisms to alter innate immune responses. Understanding these cellular 
pathways provides valuable information to address future concerns. Recently, the emerging 
field of nanotechnology and the resultant explosion in exposure to inhaled engineered 
nanoparticles has led some to question the potential health risks. Although no population-
based study to date has investigated the association between nanoparticle exposure and 
respiratory tract infections, given the cellular studies reviewed below, these might be 
warranted.
PATTERN RECOGNITION RECEPTORS AND RESPONSE TO 
ENVIRONMENTAL AIR POLLUTION
Recent studies seeking to determine the receptors and intracellular signaling mechanisms 
used by airway cells to recognize pollutants and induce an inflammatory response have 
implicated pattern recognition receptors (PRRs).18 These receptors were originally identified 
as innate immune sensors that function to distinguish innocuous from pathogenic exposures 
and induce an appropriate inflammatory response. PRRs recognize conserved microbial 
ligands, termed pathogen-associated molecular patterns (PAMPs), and endogenous ligands 
derived from stressed cells, termed damage-associated molecular patterns (DAMPs).19 
Activation of PRRs results in the release of cytokines and chemokines to attract leukocytes 
and antigen-presenting cells to the site of infection or injury and trigger their maturation.20
There are several classes of PRRs, including the TLRs, C-type lectin receptors, retinoic 
acid–inducible gene I–like receptors, and NLRs.21,22 An increasing number of studies have 
demonstrated the role of TLR signaling in pollutant-induced inflammation. More recently, 
NLRs and the subset that assemble and oligomerize to form the complex known as the 
inflammasome have been implicated as an innate immune mechanism that might be 
involved in the inflammatory response to ambient pollutants.23
TLRs
The TLR family is responsible for sensing PAMPs and DAMPs and disseminating the signal 
to intracellular transcription factors, which regulate cytokine and chemokine gene 
expression. There are currently 13 identified mammalian TLRs (10 in humans and 12 in 
mice), which are classified as type 1 transmembrane receptors containing an N-terminal 
leucine-rich repeat domain, a transmembrane region, and a C-terminal cytoplasmic 
domain.24 TLRs are expressed by a wide variety of hematopoietic cells (eg, macrophages 
and dendritic cells [DCs]), as well as epithelial cells.25 Each TLR is associated with specific 
recognition patterns: extracellular TLR1, TLR2, TLR4, and TLR5 sense bacterial 
components, such as lipoproteins and the bacterial wall component LPS (also known as 
endotoxin), whereas endosomal TLR3, TLR7, TLR8, and TLR9 recognize nucleic acids.22
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Interaction of the TLR with its specific ligand results in the activation of a signaling 
cascade, leading to the production of innate effector molecules and the initiation of the 
adaptive immune response (Fig 1).26,27 TLRs signal to the cytoplasm through adaptor 
proteins, such as myeloid differentiation primary response gene 88 (MyD88), TIR domain–
containing adaptor protein, TIR domain–containing adapter-inducing IFN-β (TRIF), and 
translocation-associated membrane protein, all of which harbor a TIR domain for the 
recruitment of the adaptor protein to the TLR cytoplasmic domain through a TIR-TIR 
interaction.24 MyD88 is an adaptor protein shared by all TLRs except TLR3, which instead 
uses TRIF to signal to the cytoplasm. The TLR signaling cascades result in the activation of 
transcription factors in the cytoplasm, such as nuclear factor κ light chain enhancer of 
activated B cells (NF-κB), interferon-regulatory factors (IRFs), and mitogen-activated 
protein kinases, which then induce or inhibit the transcription of genes involved in 
inflammatory and immune responses.20,28 More detailed reviews of TLR signaling have 
been previously published.28–30
Dysfunction of the innate immune system and TLR signaling has been associated with the 
pathogenesis of several airway diseases, including acute lung injury, asthma, and COPD.20 
For example, acute lung injury can be triggered by bacterial or viral infections and 
noninfectious insults, such as environmental exposures (ozone or metals) or trauma, which 
can stimulate TLR signaling and initiate an inflammatory response and tissue 
damage.20,31,32 Additionally, TLR4, the endotoxin receptor, has been shown to play a role 
in the induction of the TH2-biased immune response in the lung and the development of 
asthma.23 Consequently, mutations in several TLRs, including TLR4, have been associated 
with asthma.20,33,34 Clearly, the TLR signaling pathways play an important role in initiating 
the immune response to PAMPs and DAMPs, which, when left unchecked, can lead to tissue 
injury and airway disease.
Neutrophilic influx is a shared characteristic of exposure to endotoxin and many airway 
pollutants, including PM, CS, and ozone, suggesting that the inflammatory response might 
be mediated by a common innate immune mechanism.35 Knowledge that TLR4 mediates the 
inflammatory response to endotoxin has led to the hypothesis that TLR4 might also be 
involved in the inflammatory response to air pollutants.23 More recently, TLRs involved in 
nucleic acid recognition and antiviral response (TLR3, TLR7, and TLR9) were also shown 
to be modified by PM or CS.36–38 Although numerous studies suggest that air pollutants 
might alter the activation of TLR signaling, expression of TLR molecules at the membrane, 
or response to ligands, it is unclear which components of the pollutants are responsible for 
these changes. TLR activation might also be mediated by a secondary messenger or DAMP 
produced in response to airway damage, such as heat shock protein 70 (Hsp70) or 
hyaluronic acid (HA).20 Here we will compare and contrast what is currently known 
regarding the effects of PM, CS, and ozone on TLR signaling.
PM
PM-associated biological components (ie, endotoxin, pollen, bacteria, fungal spores, and 
viruses), soluble metals, and organic content are hypothesized to stimulate a 
proinflammatory response in the airway that might be mediated by TLR activation.18,39–43 
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There are several published studies that investigate the mechanism of PM recognition by 
TLRs. Becker et al40 demonstrated the involvement of TLR2 and TLR4 in the inflammatory 
response to PM2.5-10 using Chinese hamster ovary cells transfected with CD14 and TLR2 or 
TLR4. Alveolar macrophages were then treated with a TLR4 antagonist (E5531), which 
inhibited the PM2.5-10-induced inflammatory response. In contrast to alveolar macrophages, 
exposure of primary human airway epithelial cells to various sizes of PM resulted in TLR2-
dependent, TLR4-independent production of IL-8. This response was associated with low 
expression of TLR4 by the epithelial cells. Interestingly, levels of the DAMP Hsp70 were 
also increased by PM treatment, suggesting indirect activation of the TLR pathway.44 
Recently, Shoenfelt et al18 suggested that ambient air particles might use distinct receptors 
and proinflammatory signaling pathways based on particle composition. Exposure of murine 
peritoneal macrophages to PM2.5, which had high levels of redox active metals and low 
levels of endotoxin, induced cytokine secretion in a TLR2-dependent mechanism. By 
comparison, exposure to PM10, which had high levels of endotoxin, induced cytokine 
secretion in a TLR4-dependent mechanism. Both inflammatory responses were dependent 
on MyD88 expression, which is consistent with the shared use of MyD88 by TLR2 and 
TLR4. These studies demonstrate the ability of certain TLRs to recognize PM or PM-
induced danger signals and induce an inflammatory response.
In addition to acting as a TLR ligand, PM might modify the ability of TLRs to respond to 
other ligands and change the nature of the inflammatory response. In a coculture of human 
monocytes and airway epithelial cells, treatment with diesel exhaust particles (DEPs) 
enhanced the inflammatory response to low levels of the TLR agonists LPS and flagellin, 
suggesting that low-level exposure to a pollutant can enhance the proinflammatory potential 
of future stimuli.45 Modifications in the TLR response to an agonist might be the result of 
altered receptor expression. For example, respiratory epithelial cells exposed to a suspension 
of aqueous DEPs had increased expression and activity of TLR3, as evidenced by increased 
IL-6 and IFN-β expression in response to the agonist polyinosinic:polycytidylic acid.36 In 
another study, human airway epithelial cells exposed to PM had increased TLR4 expression 
and IL-8 production, whereas TLR2 expression remained constant.44 In contrast to the 
airway epithelial cell response to PM, Williams et al46 demonstrated downregulation of 
TLR2 and TLR4 expression in human myeloid DCs exposed to PM, which correlated with a 
pro-TH2 inflammatory profile (decreased IL-12 and IL-6 secretion and increased IL-18 and 
IL-10 secretion). Thus in addition to acting as a TLR ligand, PM can also prime the airway 
for a more severe or proallergic response to a subsequent challenge by influencing TLR 
expression and response.
CS
Similar to PM, CS exposure induces a proinflammatory response while concurrently altering 
TLR expression and the ability to respond appropriately to PAMPs. Several studies have 
shown that acute exposure to CS activates TLR4 signaling, leading to neutrophilic 
inflammation of the airway. Doz et al47 found that acute exposure of Tlr4−/−, Il-1r1−/−, or 
Myd88−/− mice to CS resulted in fewer neutrophils; reduced IL-1, IL-6, and keratinocyte 
chemoattractant levels; and lower matrix metal-lopeptidase 9 activity in the bronchoalveolar 
lavage (BAL) fluid compared with those seen in wild-type mice, suggesting that the airway 
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inflammation was dependent on TLR4/MyD88 and IL-1 receptor 1/MyD88 signaling. The 
inflammation was not mediated by endotoxin contamination because CS inhalation did not 
induce bronchoconstriction, a phenotype of endotoxin exposure. Moreover, the 
inflammatory effect of CS condensate on in vitro–cultured, bone marrow–derived 
macrophages was not affected by the addition of polymyxin, an endotoxin inhibitor. 
Interestingly, CS exposure also heightened levels of the known TLR4 agonist Hsp70 in BAL 
fluid, suggesting that inflammation might be mediated by a DAMP rather than direct 
stimulation of TLR4.47 Therefore CS might activate TLR4 independently of endotoxin 
exposure through either direct stimulation or a danger signal.
In vitro exposure to cigarette smoke extract (CSE) also induced the production of TLR-
mediated proinflammatory cytokines in airway macrophages, plasmacytoid dendritic cells 
(pDCs), and airway epithelial cells.48–50 Pace et al49 documented that airway epithelial cells 
exposed to CSE caused increased expression of TLR4 and heightened production of IL-8, a 
neutrophil chemoattractant.48 Likewise, Mortaz et al48 demonstrated that the production of 
IL-8 was increased by CSE treatment in pDCs. In both of these studies, combined exposure 
of CSE and TLR agonist further increased IL-8 production while decreasing production of 
other cytokines and chemokines, including TNF-α, IL-6, interferon α (IFN-α), and IFN-γ–
induced protein 10 (IP-10). These studies suggest that CS might activate TLR4, resulting in 
the induction of some proinflammatory mediators while decreasing the production of other 
cytokines.
Despite the high level of inflammation in the airway, smokers are known to have poor 
antiviral defense, which is hypothesized to be in part due to altered TLR stimulation and 
cytokine production. As mentioned above, CSE exposure decreased production of important 
innate immune cytokines, including the leukocyte chemoattractant IP-10 in airway epithelial 
cells and the immune cell activator IFN-α in pDCs.48,49 CSE was also found to inhibit 
respiratory syncytial virus–induced IFN-α, IL-1β, IL-10, and IP-10 in pDCs while not 
affecting the production of other cytokines and chemokines, including IL-6 and TNF-α. The 
reduction of IFN-α production correlated with decreased expression of TLR7 and 
phosphorylation of downstream IRF7.37 Thus CS might potentiate viral symptoms by 
increasing the proinflammatory environment of the lung while compromising the ability of 
TLRs to recognize and respond to other stimuli, such as viral infections.
Ozone
The oxidant gas ozone has also been shown to alter innate immune response and host 
defense through a TLR4-dependent mechanism.23,51 The involvement of TLR4 in ozone-
induced airway injury was first reported by Kleeberger et al,52 who examined the response 
of C3H/HeJ, Tlr4−/− (HeJ) mice to ozone. Compared with wild-type C3H/HeOuJ mice, the 
HeJ mice had decreased airway permeability and TNF-α expression. Further 
characterization of the murine model indicated that Tlr4−/− HeJ mice exposed to ozone had 
reduced expression of inducible nitric oxide synthase, an enzyme important for the 
production of nitric oxide (NO).53 Because NO plays a role in endotoxin-induced acute lung 
injury and alveolar epithelial permeability,54 this finding suggests that TLR4 modulation of 
NO synthesis might be one mechanism by which ozone induces airway injury. Subsequent 
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study of genetically modified Tlr4−/− mice (C57BL/6, Tlr4−/−) exposed to ozone indicated 
that ozone-induced airway hyperresponsiveness was dependent on intact TLR4 signaling. 
Interestingly, the Tlr4−/− and wild-type mice had a similar inflammatory response to ozone, 
as indicated by comparable neutrophil, cytokine, and protein content in the BAL fluid.55 
These results suggest that the activation and modulation of TLR4 signaling is an important 
process in the development of ozone-induced airway injury.
Beyond the mechanistic murine models, TLR4 has been suggested to play a role in the 
asthmatic human response to ozone. Similar to other air pollutants, ozone has been shown to 
heighten airway inflammation and modulate the response to subsequent inhaled allergen, 
particularly in asthmatic subjects who have underlying airway inflammation.5,56 A recent 
human study of atopic asthmatic, nonatopic asthmatic, and healthy subjects exposed to 0.4 
ppm ozone revealed that the expression of TLR4 by airway macrophages isolated from 
induced sputum was increased in atopic asthmatic subjects.35 This finding was correlated 
with increased sputum neutrophil numbers and IL-8, IL-6, and IL-1β production. Because 
asthma is a risk factor for acute ozone-associated respiratory disease, this study suggests that 
TLR4 might be a pathway through which ozone causes an inflammatory response in allergic 
asthmatic subjects.
Although these studies indicate a role for TLR4 in response to ozone, specifically how 
ozone activates TLR4 remains unclear. It is doubtful that ozone, an oxidant gas, is directly 
recognized by a discrete receptor. Several groups have suggested that ozone-induced airway 
injury results in the release of DAMPs, which can activate TLR signaling and cause an 
inflammatory response. Garantziotis et al57 hypothesized that HA can facilitate the 
inflammatory response to ozone. Mice challenged with ozone had increased HA levels in the 
BAL fluid. In line with this finding, mice deficient in the primary HA receptor, CD44, had 
decreased airway hyperresponsiveness and inflammation in response to ozone. Further 
studies by this group indicated that Tlr4−/− mice (C57BL/6, Tlr4−/−) were protected from 
airway hyperresponsiveness after ozone exposure and intratracheal instillation of low-
molecular-weight HA. In vitro exposure of bone marrow–derived macrophages to HA 
resulted in the induction of NF-κB and the production of proinflammatory cytokines in a 
pattern characteristic of TLR4 activation.58 In addition to HA, levels of Hsp70, a known 
TLR4 ligand, have been shown to be upregulated in C3H/HeOuJ mice after ozone 
exposure.59 Mice deficient in Hsp70 (Hspa1a/hspa1btm1Dix [Hsp70−/−]) had reduced 
ozone-induced inflammation and MyD88 upregulation compared with wild-type (Hsp70+/+) 
mice. Together, these studies suggest that ozone-induced inflammation and TLR4 activation 
are mediated by a secondary messenger or DAMP.
TLR summary
In summary, this discussion on the effect of air pollutant exposure on TLR signaling 
highlights several common themes (Fig 2). It is not clear which component of the air 
pollutants induce a TLR response or whether the effect is mediated by a secondary 
messenger, such as a DAMP. In the context of PM, endotoxin contamination is likely one 
constituent that induces TLR signaling. However, for pollutants such as ozone, it is much 
more likely that a DAMP mediates the TLR response. Regardless of the mechanism, it is 
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apparent that air pollutants activate TLR signaling, resulting in a proinflammatory response 
in the lung. In the process, air pollutants can prime the airway for a modified immune 
response to subsequent stimuli (eg, by shifting the leukocyte TH1/TH2 profile or reducing 
the production of antiviral cytokines). This effect might be due to alterations in TLR 
expression. Alternatively, air pollutants might overload the ability of TLRs to respond to 
ligands. Pollutant-induced alterations in TLR recognition of pathogens might contribute to 
the increased susceptibility and severity of viral infections and pollutant-induced 
pathogenesis of airway diseases such as asthma. Further research is necessary to clarify 
these mechanisms and reveal the implications of pollutant exposure on human disease.
THE INFLAMMASOME AND NLRS
In addition to the membrane-associated TLRs, PAMPs and DAMPs are also recognized by 
the cytosolic NLR family of PRRs. NLRs include proteins such as nucleotide-binding oligo-
merization domain 1 and 2, NOD-like receptor protein 3 (NLRP3, or cryopyrin), and NLR 
family CARD domain–containing protein 4 (or IPAF). Engagement of these receptors 
results in a cascade of intracellular signaling, leading to the initiation of an innate immune 
response.60–62 On recognition of a PAMP or DAMP, certain NLRs can form a multiprotein 
complex termed the inflammasome. The inflammasome is composed of a PRR (NLR or the 
IFI200 family member absent in melanoma 2), procaspase-1, and the adaptor protein 
apoptosis speck-like protein containing a CARD (also known as PYCARD).61 This complex 
has been most studied in myeloid cells, particularly macrophages, although recently there 
has been increased interest in inflammasome signaling in nonmyeloid cells.63
On formation of the inflammasome complex, caspase-1 is autoactivated from the proform to 
the cleaved active form, which can then catalyze the proteolytic processing and release of 
IL-1β, IL-18, and IL-33 (Fig 3). Active caspase-1 might also participate in one of several 
other effector mechanisms, including induction of a caspase-1–dependent form of 
programmed cell death termed pyroptosis.64,65 Caspase-1–mediated processing and the 
release of mature cytokines require 2 distinct stimuli. First, an inflammatory stimulus 
activates the transcription of procytokines, such as pro–IL-1β and pro–IL-18. This signal can 
be triggered by TLR activation and downstream signaling through the NF-κB or mitogen-
activated protein kinase pathways. The second signal induces activation of the 
inflammasome, cleavage of caspase-1, and hence procytokine maturation and release.
The exact mechanism of inflammasome activation is not clear. For the prototypical NLRP3 
inflammasome, there are 3 proposed models of activation, all of which include cytoplasmic 
potassium (K+) efflux from the cell as an important step for inflammasome activation (Fig 
3).66–68 The channel model of inflammasome activation suggests that ATP-mediated 
activation of the membrane-associated purinergic receptor P2X purinoceptor 7 triggers 
membrane permeability, K+ efflux, and pannexin-1 channel recruitment, thereby allowing 
direct interaction of the agonist with the NLR.60,66,69 Endogenous ATP is a known NLRP3 
agonist that is released by injured or necrotic cells. ATP is not required for activation of the 
inflammasome by some bacterial pathogens, and thus this model might not apply to all 
NLRP3 agonists.60 An alternate hypothesis is the lysosome rupture model, which suggests 
that the uptake of large particulate activators (eg, alum, asbestos, and silica) leads to 
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phagosomal destabilization, lysosomal rupture, and release of the lysosomal protein 
cathepsin B, which directly or indirectly triggers inflammasome activation.70 Finally, the 
third model proposes that NLRP3 acts as a broad sensor of cellular injury through 
recognition of oxidative stress, which commonly occurs with K+ efflux.70,71 Reactive 
oxygen species (ROS) are generated within and outside of the cell by many NLRP3 
agonists, including ATP and the particulate activators asbestos and silica, and thus might 
play a crucial role in inflammasome activation. Because of the wide range of stimuli 
recognized by NLRP3, inflammasome activation likely involves a combination of these 
mechanisms and is tailored for specific stimuli.
Through the recognition of pollutants or pollutant-induced danger signals, the 
inflammasome might be a pathway by which environmental air pollutants stimulate an 
innate immune response. Alterations in inflammasome signaling are associated with 
inflammatory diseases, including gout, autoimmunity, atherosclerosis, Crohn disease, 
ulcerative colitis, and metabolic disorders.72 Moreover, it has recently been shown that lung 
transplant tissue from chronic smokers and patients with COPD has been shown to have 
enhanced caspase-1 activity compared with that seen in nonsmokers.73 Thus it is likely that 
modified inflammasome signaling, as caused by a pollutant exposure or an underlying 
inflammatory disease, might lead to altered inflammatory responses to pathogens and 
particles and enhanced pathogenesis in the airway.
The first indication of inflammasome involvement in pollutant-induced inflammation was 
the finding that the NLRP3 inflammasome was activated by aluminum salts, silica crystals, 
and asbestos particles in primary murine and human macrophages and the human THP-1 
(monocyte) cell line.70,74 In both of these studies, the activation of NLRP3 was attributed to 
phagosomal destabilization. However, Hornung et al74 hypothesized that NLRP3 activation 
was mediated by lysosomal damage and the release of the lysosomal protein cathepsin B, 
whereas Dostert et al70 suggested that K+ efflux and the generation of ROS was responsible 
for inflammasome activation. On the basis of these initial findings, the inflammasome has 
since been shown to be activated by CS47 and nanoparticles75,76 but, as yet, not by 
DEPs.45,70
Nanoparticles
Because of their unique size and physiochemical properties, nanoparticles are becoming 
increasingly useful for numerous medical (eg, drug delivery), consumer, and industrial 
applications. However, these same properties raise safety concerns for potential adverse 
effects on the respiratory system, which serves as both a portal of entry for inhaled particles 
and a receiver of cardiac output.77 Although the toxicity of nanoparticles remains unclear, 
an increasing number of studies highlight the potential respiratory toxicity of nanoparticles, 
including several recent studies that indicate that nanoparticles might induce pulmonary 
inflammation and respiratory disease through a mechanism involving activation of the 
inflammasome.75,76,78 Using genetically engineered mice, Yazdi et al75 reported that the 
IL-1 receptor was necessary for induction of lung inflammation by titanium dioxide (TiO2) 
nanoparticles, suggesting an important role for inflammasome signaling. Using in vitro 
cultures, TiO2 and silicon dioxide nanoparticle exposure was shown to activate the NLRP3 
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inflammasome and IL-1β release in LPS-primed murine bone marrow–derived macrophages 
and human THP-1 cells. Interestingly, phagocytosis was not required for inflammasome 
activation by the nanoparticles because silicon dioxide nanoparticles also activated IL-1β 
secretion in nonphagocytic keratinocytes. Thus nanoparticle exposure might activate the 
inflammasome through a yet to be determined mechanism, resulting in lung inflammation.
In addition to inflammasome regulation of IL-1β release, certain nanoparticles have also 
been shown to induce an inflammasome-dependent form of cell death termed pyroptosis. 
Carbon-based nanoparticles are a major constituent of diesel exhaust and ambient PM and 
are known to cause oxidative stress, inflammation, and cytoxicity.79 In a recent study, 
Reisetter et al76 demonstrated that exposure of unprimed macrophages (both the RAW264.7 
cell line and primary human alveolar macrophages) to carbon-based nanoparticles, but not 
TiO2, induced caspase-1–dependent pyroptosis, as evidenced by the loss of plasma 
membrane integrity, lactate dehydrogenase release, and cellular swelling. Interestingly, 
carbon-based nanoparticle exposure alone did not induce IL-1β release from macrophages. It 
was only after LPS priming that the nanoparticles activated caspase-1 to its cleaved form 
and increased IL-1β release. These findings suggest that the involvement of caspase-1 in 
activities other than IL-1β secretion, such as pyroptosis, might require a different mode of 
activation independent of TLR activation and cytokine processing. Thus although many 
studies focus on IL-1β secretion as a marker of inflammasome activation, activity can also 
be measured through other end points, such as membrane permeability and lactate 
dehydrogenase release.
CS
Although nanoparticles act as inflammasome activators, other pollutants might instead be 
involved in the initiation of procytokine transcription through activation of TLR signaling. A 
recent study of CS exposure by Doz et al47 highlighted the important association between 
TLR signaling and inflammasome activation. CS was shown to induce inflammation and 
increase IL-1β production in the lungs of wild-type mice. However, in mice deficient in IL-1 
receptor type 1 (Il-1r1−/−), exposure to CS resulted in significantly decreased airway 
inflammation, suggesting that IL-1 signaling was an important mediator of this process. 
Cultured murine bone marrow–derived macrophages were exposed to cigarette smoke 
condensate (CSC) and then stimulated with either CSC or ATP to further investigate this 
finding. CSC exposure alone induced the production of pro–IL-1β but not the release of 
mature IL-1β, whereas the addition of ATP resulted in both the production of pro–IL-1β and 
the release of mature IL-1β. The release of IL-1β was abrogated in Tlr4−/− mice. Thus CSC 
activation of TLR signaling induced production of pro–IL-1β, but a second signal, such as 
ATP, was needed to activate the inflammasome complex. These results suggest that by 
modulating the activation of TLRs and hence procytokine production, pollutants can prime 
the cell for an inflammasome-mediated inflammatory response to a second stimulus.
Diesel exhaust
Beyond acting as stimulators of TLR and NLR signaling, environmental pollutants can 
indirectly modify inflammasome function by interfering with inflammasome agonists. DEPs 
are an interesting example of this phenomenon. In an initial study on the effect of 
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particulates on inflammasome activation, Dostert et al70 reported that exposure of THP-1 
cells to DEPs did not result in IL-1β production. A recent study by Chaudhuri et al45 
elucidated this finding by demonstrating that DEPs had the ability to sequester or breakdown 
ATP and thereby prevent IL-1β processing and release. By using an epithelial cell/monocyte 
coculture, it was found that monocyte-derived IL-1 was important for the production of 
proinflammatory mediators in response to LPS exposure, yet cocultures stimulated with 
combined LPS and DEPs did not have detectable IL-1β. Interestingly, DEP exposure did not 
alter the production or cleavage of pro–IL-1β, and incubation of DEPs with IL-1β did not 
inhibit recovery or biological action. However, it was found that incubation of ATP with 
DEPs resulted in a rapid decrease in recoverable ATP. These results suggest that DEPs have 
the capability to inhibit IL-1β release by interfering with ATP, a molecule known to be 
involved in IL-1β processing and highlights the possibility that environmental pollutants can 
alter inflammasome signaling by impeding inflammasome activators.
Inflammasome summary
It is clear that environmental pollutants can modulate or activate the inflammasome, leading 
to the production of proinflammatory cytokines. Pollutants are involved in and might 
interfere with all steps of inflammasome activity, from the initiation of procytokine 
production to the activation of the NLRs and the release of mature cytokines. Although these 
processes are only beginning to be understood, pollutants might also induce caspase-1 
activities beyond cytokine processing, such as pyroptotic cell death. Although most of these 
studies investigate pollutant-induced activation of the NLRP3 inflammasome, little is known 
about the effect of pollutants on other inflammasomes, such as NLRP1, NLR family CARD 
domain–containing protein 4, or absent in melanoma 2. Although the pollutant might not be 
specifically recognized by other receptors, pollutants might act as a general stimulant of 
inflammasome signaling through the initiation of procytokine production. The 
understanding that procytokine processing requires both TLR and inflammasome activation 
demonstrates that there is clear cooperation between the TLR and NLR signaling pathways. 
By acting as a signal for either TLR or NLR signaling, a pollutant might prime the cell for a 
heightened or modified inflammatory response to a second immune stimulus. In addition, 
pollutant-induced DAMPs, such as the extracellular matrix proteins HA79 and biglycan,80 
can activate both TLR and inflammasome activity. Ozone induces the release of ATP by 
epithelial cells in vitro81 and increases levels of HA in animals and human subjects,35,57 yet 
the role of inflammasome-mediated signaling in ozone-induced changes in respiratory 
immune responses is poorly understood and needs to be further investigated. Future research 
on the interaction between TLR and NLR signaling might elucidate the adjuvant capabilities 
of environmental air pollutants and provide another link between pollutant exposure and 
human airway disease.
CONCLUSION
Recent discoveries in signaling pathways mediating innate immune responses provide the 
basis to further our mechanistic understanding of how air pollutants increase susceptibility 
to pathogens or severity of infection. However, there are several considerations that warrant 
follow-up studies based on the information provided here.
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First, it is likely that pollutant-induced modifications of innate immune responses and the 
roles of TLR and NLR pathways are cell type specific. For example, NLRP3 is highly 
expressed in monocytes/macrophages, conventional DCs, and neutrophils but not in T cells, 
B cells, natural killer cells, and eosinophils82 or nonmyeloid cells, such as airway epithelial 
cells.83 Studies examining the effects of pollutants on NLR signaling are primarily 
conducted in models of monocytes/macrophages, which need to be expanded to include 
other cell types likely to be directly affected by pollutants, such as epithelial cells. Similarly, 
epithelial cells express TLR1 to TLR6 and TLR9 and respond to activation with microbial 
ligands specific for TLR2, TLR3, and TLR4.84–86 Thus pollutant-induced modulations of 
TLR and NLR pathways are anticipated to differ among myeloid cells and between immune 
cells and epithelial cells.
Second, one of the clinically most relevant adverse effects of pollution exposure is 
exacerbation of pre-existing lung diseases, such as asthma and COPD. Expression, 
localization, or both of TLRs are modified in epithelial cells from asthmatic subjects87 or 
smokers,49 which might affect pollutant-induced effects on TLR signaling. Thus whether 
and how the disease state alters the effects of air pollutants on TLR and NLR signaling 
should be considered.
In conclusion, concurrent exposures to pollutants and pathogens are likely, thus making 
potential interactions between the 2 insults and mechanisms mediating these responses of 
great public health importance.
GLOSSARY
CATHEPSIN Cathepsins are proteases that are found in lysosomes. 
Newly discovered functions for cathepsins include 
activation of the innate immune system. For example, 
cathepsin K activates the innate immune system by 
altering TLR9 signaling and inhibiting the production of 
IL-6, IL-23, and TH17 cells. Phagocytosis of large 
particles has been shown to cause lysosomal 
destabilization, leading to the release of cathepsin B from 
the lysosome and the activation of the NLRP3 
inflammasome
CLEAN AIR ACT The US Clean Air Act was first signed in 1970 and was 
followed by a number of amendments in 1977 and 1990. 
The purpose of the Clean Air Act was to protect the public 
from exposure to high levels of air pollutants. In 1990, the 
US Environmental Protection Agency estimated that it 
prevented more than 200,000 premature deaths and almost 
700,000 cases of chronic bronchitis in its first 20 years. 
Since 1970, total emissions of the 6 principal air 
pollutants have decreased by greater than 41%
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HA is a major component of the extracellular matrix 
protein that is found in connective, epithelial, and neural 
tissues. HA is an endogenous DAMP that is recognized by 
the innate immune system through TLR2 and TLR4, 
thereby inducing interleukin production (eg, IL-8)
IL-6 IL-6 acts as both a proinflammatory and anti-
inflammatory agent but is most commonly associated with 
acute-phase reactions and fever. IL-6 is released by 
numerous cell types, including macrophages, dendritic 
cells, T cells, and epithelial cells. IL-6 can be released in 
response to various microbial stimuli through activation of 
pattern recognition receptors (eg, Toll-like receptors)
IL-33 IL-33 is an IL-1 family member that is produced by 
epithelial cells, smooth muscle cells, and fibroblasts. 
IL-33 induces the production of type 2 cytokines, such as 
IL-5 and IL-13, from TH2 cells, mast cells, eosinophils, 
and basophils. IL-33 is transcribed in a proform, which 




IP-10 (also known as CXCL-10) is secreted by several 
cell types, such as endothelial cells, epithelial cells, 
fibroblasts, and monocytes, in response to microbial, IFN-
γ, or TNF-α stimulation. IP-10 is involved in 
chemoattraction of T and natural killer cells and binds to 
CXCR3
INTERFERONS Interferons are a class of cytokines produced in response 
to pathogenic infections and tumors. The interferon family 
consists of type I (IFN-α and IFN-β), type II (IFN-γ), and 
type III (IFN-λ) interferons. Interferons are produced by 
activation of Toll-like receptor and retinoic acid–inducible 
gene I–like receptor signaling. Interferons play a key role 
in innate immunity through such functions as antiviral 
defense, activation of immune cells (eg, natural killer cells 
and macrophages), and upregulation of antigen 




MMPs, or matrix metalloproteinases, break down 
extracellular matrix and promote tissue remodeling. 
MMPs are involved in several physiologic and pathologic 
processes, including tissue repair, angiogenesis, 
morphogenesis, cirrhosis, and metastasis. The activity of 
MMPs is balanced by tissue inhibitors of 
metalloproteinases (TIMPs). Misbalance between MMPs 
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MyD88 is an adaptor protein for all Toll-like receptors 
except Toll-like receptor 3, as well as IL-1 receptors. 
MyD88 serves as a link between the extracellular 
receptors and intracellular signaling pathways leading to 
activation of the transcription factor NF-kB and 
expression of many genes important for innate immunity. 
Autosomal recessive MyD88 deficiency causes increased 
susceptibility to Streptococcus pneumoniae, 
Staphylococcus aureus, and Pseudomonas aeruginosa, as 
well as other gram-negative infections
NANONOPARTICLES Nanoparticles are between 1 and 100 nm in size and have 
been used for consumer, manufacturing, and medical 
purposes (eg, drug delivery). Inhalation of nanoparticles 
has uncertain pulmonary toxicity but has been 
increasingly shown to have potential adverse effects on 
the respiratory tract and vasculature
OZONE Ozone is a naturally occurring gas, which can be formed 
at low levels in the atmosphere through the interaction 
between hydrocarbons and nitrogen oxides (eg, as 
produced by fuel exhaust) and sunlight. Because of its 
strong oxidizing capabilities, ozone is a primary irritant 
and can affect the eyes and respiratory system. Ozone can 
induce the production of reactive oxygen species, leading 
to oxidative stress and tissue and cellular damage
PARTICULATE MATTER 
(PM)
PM consists of solid and liquid compounds from organic, 
inorganic, and biological sources. A major source of PM 
is diesel exhaust. PM is broken into the following 3 
classes by size: coarse (PM2.5-10), fine (PM0.1-2.5), and 
ultrafine (PM<0.1). Fine and ultrafine particles are capable 
of depositing into the lung, with ultrafine particles 
reaching the small airways. The components of PM are 
toxic to cells and can induce DNA damage. Chronic 
exposure has been associated with airway diseases, such 
as asthma, and cardiovascular disease
Abbreviations used
BAL Bronchoalveolar lavage
COPD Chronic obstructive pulmonary disease
CS Cigarette smoke
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CSC Cigarette smoke condensate
CSE Cigarette smoke extract
DAMP Damage-associated molecular pattern
DC Dendritic cell
DEP Diesel exhaust particle
HA Hyaluronic acid
Hsp70 Heat shock protein 70
IP-10 IFN-γ–induced protein 10, also known as CXCL10
IRF Interferon-regulatory factor
MyD88 Myeloid differentiation primary response gene 88
NF-κB Nuclear factor κ light chain enhancer of activated B cells
NLR NOD-like receptor
NLRP NOD-like receptor protein
NO Nitric oxide
NOD Nucleotide-binding oligomerization domain
PAMP Pathogen-associated molecular pattern
pDC Plasmacytoid dendritic cell
PM Particulate matter
PRR Pattern recognition receptor




TRIF TIR domain–containing adapter-inducing IFN-β
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Summary of TLR signaling. TLRs are transmembrane receptors that might exist either 
extracellularly at the cellular membrane or intracellularly at the endosomal membrane. Each 
TLR recognizes specific ligands and signals to cytosolic molecules through adaptor proteins, 
including translocation-associated membrane protein (TRAM), TRIF, TIR domain–
containing adaptor protein (TIRAP), and MyD88. The end result of TLR signaling is the 
activation of mitogen-activated protein kinase (MAPK), NF-κB, and IRF3/7, leading to the 
transcription of proinflammatory cytokines and IFN-inducible genes. dsRNA, Double-
stranded RNA; JNK, c-Jun N-terminal kinase; ssRNA, single-stranded RNA.
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Exposure to air pollutants modifies TLR-dependent signaling. Air pollutants, such as PM, 
ozone, and CS, might activate TLR signaling through either direct interaction with the 
receptor or through the production of a secondary mediator, such as a DAMP. Alternatively, 
the pollutants might indirectly alter TLR signaling by modifying the response to a PAMP or 
DAMP. Modifications in TLR signaling result in altered cytokine profiles and an enhanced 
proinflammatory response in the lung.
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NLR- and inflammasome-dependent signaling is altered by exposure to air pollutants. Air 
pollutants are involved in or interfere with all steps of inflammasome activity. CS and PM-
associated endotoxin (LPS) initiate the production of pro–IL-1β through activation of TLR 
signaling. Nanoparticles, silica, and asbestos directly activate NLR signaling and 
inflammasome formation through a mechanism that might involve phagocytosis, lysosome 
rupture, potassium (K+) efflux, and the production of ROS. Nanoparticles might induce 
additional caspase-1 activities, including pyroptosis. Pollutant-induced DAMPs, such as HA 
(induced by ozone exposure), can also act as activators of TLRs and NLRs. Air pollutants 
can also inhibit inflammasome activities. DEPs were shown to scavenge the inflammasome 
activator ATP and prevent mature cytokine release.
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